X4 Pharmaceuticals (STU:48Q) Days Payable : 3,371.13 (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is X4 Pharmaceuticals Days Payable?

X4 Pharmaceuticals's average Accounts Payable for the three months ended in Sep. 2024 was €7.57 Mil. X4 Pharmaceuticals's Cost of Goods Sold for the three months ended in Sep. 2024 was €0.21 Mil. Hence, X4 Pharmaceuticals's Days Payable for the three months ended in Sep. 2024 was 3,371.13.

The historical rank and industry rank for X4 Pharmaceuticals's Days Payable or its related term are showing as below:

STU:48Q' s Days Payable Range Over the Past 10 Years
Min: 0 Med: 0 Max: 6279.03
Current: 6279.03

During the past 9 years, X4 Pharmaceuticals's highest Days Payable was 6279.03. The lowest was 0.00. And the median was 0.00.

STU:48Q's Days Payable is ranked better than
93.84% of 714 companies
in the Biotechnology industry
Industry Median: 127.37 vs STU:48Q: 6279.03

X4 Pharmaceuticals's Days Payable increased from Sep. 2023 (0.00) to Sep. 2024 (3,371.13). It may suggest that X4 Pharmaceuticals delayed paying its suppliers.

X4 Pharmaceuticals Days Payable Historical Data

The historical data trend for X4 Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

X4 Pharmaceuticals Days Payable Chart

X4 Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

X4 Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Payable	Get a 7-Day Free Trial															-	-	-	2,865.58	3,371.13

Competitive Comparison of X4 Pharmaceuticals's Days Payable

For the Biotechnology subindustry, X4 Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

X4 Pharmaceuticals's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, X4 Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where X4 Pharmaceuticals's Days Payable falls into.

X4 Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

X4 Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (7.341	+	8.204)	/	2 )	/	0	*	365
=	7.7725					/	0	*	365
=	N/A

X4 Pharmaceuticals's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (7.419	+	7.728)	/	2 )	/	0.205	*	365 / 4
=	7.5735					/	0.205	*	365 / 4
=	3,371.13

X4 Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of X4 Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

X4 Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » X4 Pharmaceuticals Inc (STU:48Q) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

XFOR:USA

Address

61 North Beacon Street, 4th Floor, Boston, MA, USA, 02134

Website

https://www.x4pharma.com

X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It has the ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

X4 Pharmaceuticals Headlines

No Headlines